Trustees of Columbia University in the City of New York’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Trustees of Columbia University in the City of New York’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$820K	Hold	150,150	–	–	1.25%	12
2021 Q2	$1.12M	Hold	150,150	–	–	1.65%	10
2021 Q1	$1.22M	Hold	150,150	–	–	1.47%	9
2020 Q4	$1.37M	Buy	+150,150	New	+$1.23M	1.83%	7

Other funds holding KLDO

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Trustees of Columbia University in the City of New York's KLDO Position: Q3 2021 in Review

Trustees of Columbia University in the City of New York held its Kaleido Biosciences, Inc. Common Stock (KLDO) position steady in Q3 2021 at 150,150 shares worth $820K. The position accounts for 1.25% of the portfolio, ranked #12.

Trustees of Columbia University in the City of New York first reported a position in KLDO in Q4 2020 and has held it in 4 quarters since. The position peaked at $1.37M in Q4 2020. 71 funds tracked by Wall St. Rank hold KLDO as of Q3 2021.

Trustees of Columbia University in the City of New York held 150,150 shares of Kaleido Biosciences, Inc. Common Stock worth $820K as of Q3 2021.
Trustees of Columbia University in the City of New York left its Kaleido Biosciences, Inc. Common Stock share count unchanged in Q3 2021.
Kaleido Biosciences, Inc. Common Stock made up 1.25% of Trustees of Columbia University in the City of New York's portfolio in Q3 2021, its #12 holding.
Trustees of Columbia University in the City of New York first reported a position in Kaleido Biosciences, Inc. Common Stock in Q4 2020 and has held it in 4 quarters since.
Trustees of Columbia University in the City of New York's Kaleido Biosciences, Inc. Common Stock position peaked at $1.37M in Q4 2020.
71 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q3 2021.

Based on Trustees of Columbia University in the City of New York's 13F filing for Q3 2021, filed 15 Nov 2021.